Bilateral adrenalectomy for palliative treatment of prostatic cancer
- PMID: 4117197
- DOI: 10.1016/s0022-5347(17)60911-x
Bilateral adrenalectomy for palliative treatment of prostatic cancer
Similar articles
-
[Treatment of pain in bone metastases of prostatic carcinoma through unilateral left adrenalectomy].J Urol Nephrol (Paris). 1973 Dec;79(12 Pt 2):415-9. J Urol Nephrol (Paris). 1973. PMID: 4140920 French. No abstract available.
-
Technique of bilateral palliative adrenalectomy.Surg Gynecol Obstet. 1967 Jul;125(1):121-2. Surg Gynecol Obstet. 1967. PMID: 4165219 No abstract available.
-
Major endocrine ablation for carcinoma of the breast and prostate.Clin Otolaryngol Allied Sci. 1978 May;3(2):213-21. doi: 10.1111/j.1365-2273.1978.tb00686.x. Clin Otolaryngol Allied Sci. 1978. PMID: 78779 No abstract available.
-
The current role of hormonal therapy in the clinical treatment of prostatic cancer.Semin Urol. 1988 Nov;6(4):269-78. Semin Urol. 1988. PMID: 3068766 Review. No abstract available.
-
Carcinoma of the prostate: a review.J Urol. 1978 Jan;119(1):1-8. doi: 10.1016/s0022-5347(17)57365-6. J Urol. 1978. PMID: 74424 Review. No abstract available.
Cited by
-
Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis.Oncogene. 2014 May 29;33(22):2815-25. doi: 10.1038/onc.2013.235. Epub 2013 Jun 10. Oncogene. 2014. PMID: 23752196 Free PMC article. Review.
-
Mechanisms mediating androgen receptor reactivation after castration.Urol Oncol. 2009 Jan-Feb;27(1):36-41. doi: 10.1016/j.urolonc.2008.03.021. Urol Oncol. 2009. PMID: 19111796 Free PMC article. Review.
-
Remission of progressive metastatic castration-resistant prostate cancer during abiraterone therapy following unilateral adrenalectomy for a functioning adrenal adenoma.BMJ Case Rep. 2022 Oct 5;15(10):e251036. doi: 10.1136/bcr-2022-251036. BMJ Case Rep. 2022. PMID: 36198431 Free PMC article.
-
Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer.Clin Cancer Res. 2009 Nov 15;15(22):7099-105. doi: 10.1158/1078-0432.CCR-09-1722. Epub 2009 Nov 3. Clin Cancer Res. 2009. PMID: 19887483 Free PMC article. Clinical Trial.
-
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors.Cancer Res. 2011 Oct 15;71(20):6503-13. doi: 10.1158/0008-5472.CAN-11-0532. Epub 2011 Aug 25. Cancer Res. 2011. PMID: 21868758 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources